Skip to main content

Vantiva – Results Full Year 2025

Press Release Results Full Year 2025 REVENUES: €1,736 MILLION vs 1,865 million in 2024ADJUSTED EBITDA: €145 MILLION vs €109 million in 20241ADJUSTED EBITA: €76 MILLION vs €46 million in 2024FCF POSITIVE: €62 MILLION vs -€25 million in 2024 Paris (France) – April 23, 2026 – Vantiva (Euronext Paris: VANTI), a global technology leader in connectivity, announces its audited results for the year 2025. Estimated Operational results were published on March 27. The Board of Directors approved the consolidated financial statements on April 23, 2026. Audit procedures have been completed, and the audit reports are being issued.Full-year sales decreased by 7.0% to €1,736 million, largely due to USD weakness (-3.1% at constant exchange rates) and Video decline coupled with a soft Q4 due to a challenging YoY comparable and some component supply delays....

Continue reading

Amendment of share sale agreement of the share of Saare Kala Tootmine OÜ and the proposal to the shareholders of AS PRFoods to adopt shareholders’ resolutions without calling a meeting

On 05.12.2025 the subsidiary of AS PRFoods (registry code 11560713) Saaremere Kala AS (registry code  11310040, hereinafter “Seller“) signed an agreement (the “SPA”) for the sale of its 100% shareholding in Saare Kala Tootmine OÜ (registry code 10377013, hereinafter “SKT“) and transfer of claims arising from shareholder loans and an inventory loan provided to SKT to the Latvian company Brīvais Vilnis A/S (Latvian registry code: 40003056186, hereinafter “Buyer“) (the “Transaction”). The main terms of the relevant Transaction and preconditions for closing thereof were disclosed in a stock exchange announcement published by AS PRFoods on 05.12.2025 “Conclusion of share sale agreement of the share of Saare Kala Tootmine OÜ and the proposal to the shareholders of AS PRFoods to adopt shareholders’ resolutions...

Continue reading

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

FDA Issued Complete Response Letter Citing Outstanding Items Related to Chemistry, Manufacturing, and Controls and Non-Clinical Information  FDA Does not Request Additional Clinical Data Company Intends to Resubmit Application Following Resolution of Cited Items PRINCETON, N.J., April 23, 2026 (GLOBE NEWSWIRE) — Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous infusion to address significant unmet medical needs in aneurysmal subarachnoid hemorrhage (aSAH) patients, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Company’s New Drug Application (NDA) for GTx-104 for the treatment of patients with...

Continue reading

Vantiva – First Quarter 2026 Sales and Refinancing

Press Release First Quarter 2026 Sales and Refinancing Revenues down 14.1% YoY (-4.0% at constant exchange rate)Refinancing agreement reached Guidance maintained Paris (France) – April 23, 2026 – Vantiva (Euronext Paris: VANTI), a global technology leader in connectivity, today announced its unaudited revenues for the first quarter of 2026. Group sales declined by 14.1% year-on-year (YoY) in the first quarter, primarily due to the depreciation of the U.S. dollar. At constant exchange rates, revenues decreased by 4%, mainly driven by lower demand for video devices.Group sales amounted to 349 million euros, down 14.1% YoY (-4% at constant exchange rates). Broadband revenues increased by 1.4% (+13.2% at constant exchange rates), while Video revenues declined by 46.7% (-40.4% at constant exchange rates). Vantiva and its current lenders have...

Continue reading

Banijay Group completes the acquisition of Tipico Group

Press Release                                                                Paris, April 23, 2026 Banijay Group completes the acquisition of Tipico Group and creates a European champion in sports betting and online gamingBanijay Gaming becomes the leader in sports betting in Continental Europe with leading positions in six key markets Following this combination, Banijay Gaming expects to double its revenue, adjusted EBITDA and adjusted free cash-flow and synergies are expected to reach c.€100 million over the mid-term Banijay Group pro forma 20251, including the combination with All3Media, would have reached €7.4 billion in revenue, €1.6 billion in adjusted EBITDA and €1.2 billion in adjusted free cash flowBanijay Group, the Entertainment powerhouse, today announces the successful completion of the acquisition of Tipico Group. The...

Continue reading

+25%: strong growth in Q1 2026 turnover

+25%: strong growth in Q1 2026 turnover First-quarter (Q1) 2026 turnover amounts to 133.3 million euros, showing a strong increase, driven by Energy Sales and the intensification of Renvolt’s activityEnergy Sales: 72.0 million euros, up +3% at constant exchange rates. The growth in the portfolio of power plants in operation more than offsets (i) the disposals of power plants completed in 20251 and (ii) the temporary reduced availability of certain plants, particularly in French Guiana2 Renvolt: 54.3 million euros, up sharply by +80% at constant exchange rates, driven by the increase in construction for third-party clients Voltalia Hub3: 7.0 million euros, up +4% at constant exchange ratesOperational capacity and production indicators as of 31 March 2026Energy production of 1.1 terawatt-hour, broadly stable (-1%) Capacity in operation...

Continue reading

LLYC Named to PRovoke Media’s “100 Best Agencies in the U.S.”

Recognition highlights firm’s growth in capital markets, cross-border advisory, and AI-driven communications GRAND RAPIDS, Mich., April 23, 2026 (GLOBE NEWSWIRE) — LLYC, a global Marketing and Corporate Affairs firm that advises companies in their most critical moments of growth, reputation and market visibility, has been named to PRovoke Media’s prestigious 100 Best Agencies in the United States for 2026. This annual ranking evaluates firms based on performance, growth, quality of work, innovation and leadership, placing LLYC among the top tier of agencies operating in one of the most competitive and sophisticated communications markets in the world. This recognition marks a defining moment in LLYC’s continued expansion in the U.S., where the firm has built a differentiated platform focused on helping growth-oriented companies...

Continue reading

SAVENCIA: Activity of the 1st quarter 2026

                 Thursday, April 23, 2026 PRESS RELEASE: Activity of the 1st quarter 2026Stable revenue on a comparable basis in a volatile environmentKey figures in €M   31/03/26   % CA   31/03/25   % CA   Changes in %Total Structure Change & IAS 29 Growth OrganicSales 1629   1 695   -3,9 0,7 -4,2 -0,4– Cheese Product 932 57,2 953 56,2 -2,2 0,0 -0,8 -1,4– Other Dairy Product 752 46,1 805 47,5 -6,6 1,5 -8,4 0,3– Unallocated -55 -3,4 -63 -3,7 -12,7 0,0 -6,8 -5,9As of March 31, 2026, Savencia Fromage & Dairy generated sales of €1,629 million, reflecting a decline of -0.4% on a comparable basis and -3.9% on a reported basis, significantly impacted by an unfavorable exchange rate effect of -4.2%, mainly due to the devaluation of the Argentine peso and Asian currencies. Regarding Cheese...

Continue reading

AS Tallink Grupp Investor Webinar introducing the results of the first quarter 2026

On 23 April 2026 AS Tallink Grupp held an investor webinar where Peep Jalakas, the Chairman of the Management Board, Paavo Nõgene and Harri Hanschmidt, the Members of the Management Board introduced the results of the first quarter 2026. AS Tallink Grupp would like to thank all the participants. The webinar presentation is enclosed and the webinar recording is available in the Company’s website under Reports & Financial key figures. Anneli SimmInvestor Relations Manager AS Tallink GruppSadama 510111 Tallinn, Estoniaemail: anneli.simm@tallink.eePhone: +372 56157170AttachmentAS Tallink Grupp Q1 2026 Webinar Presentation

Continue reading

Q1 2026 revenue

Q1 2026 revenue Quarterly activityRevenue: €177.4m, up 2.6% at CER1 and on a like-for-like basis2 Increase driven by EMEA (+4.5%), with an improvement in the situation in France, and by Asia (+6.0%); a decline in the Americas, impacted as anticipated by the situation at the Raleigh siteOperational deploymentContinued implementation of the remediation plan at the Raleigh site, in accordance with the action plan Rollout of the Group’s transformation plan in line with schedule, and the start of a procedure for informing and consulting the Economic and Social Committee a procedure for informing and consulting the Economic and Social Committee on a redundancy plan in France2026 financial targets to be communicated by 23 July at the latestVillepinte, 23 April 2026, 5.45 p.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.